Biomarkers in Acute Kidney Injury (AKI) Conference Report at Inverness Medical

The current status of the endogenous biomarker Neutrophil Gelatinase-Associated Lipocalin (NGAL) and its role in predicting renal injury in various clinical situations was addressed at the Scientific Symposium on Biomarkers in Acute Kidney Injury, which was chaired by two highly renowned experts.

The symposium reviewed our current understanding of Acute Kidney Injury (AKI) and the Cardio-Renal Syndrome (CRS), and summarized the current potential utility of NGAL in predicting AKI in the clinical settings of the Emergency Department (ED), heart dysfunction, interventional cardiology and the Intensive Care Unit (ICU). The expanding role of NGAL and its potential future applications was also touched on. This review highlights key information from the symposium.

To obtain your free copy of the full review paper click  the enquire button on the left
(please ensure you include a full postal address)

Read the rest of this article in your chosen speciality:

• Emergency Medicine|
• Cardiology|
• Intensive Care

• 1|
• 2